Cisplatin, Methotrexate and Vinblastine Plus Surgical Restaging for Patients with Advanced Transitional Cell Carcinoma of the Urothelium
- 1 July 1993
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 150 (1) , 65-69
- https://doi.org/10.1016/s0022-5347(17)35398-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1992
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.Journal of Clinical Oncology, 1990
- Biology and Management of Bladder CancerNew England Journal of Medicine, 1990
- Phase III Comparison of Cisplatin Alone Versus Cisplatin, Doxorubicin and Cyclophosphamide in the Treatment of Bladder (Urothelial) Cancer: A Southeastern Cancer Study Group TrialJournal of Urology, 1987
- Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.Journal of Clinical Oncology, 1985
- Regional Lymph Node Metastasis From Bladder CancerJournal of Urology, 1981
- A Phase 2 Study of Cis‐platinum in Patients with Recurrent Bladder CarcinomaBritish Journal of Urology, 1981
- Cis-Diamminedichloride Platinum II in the Treatment of Abvanced Bladder CancerJournal of Urology, 1980
- Cis-Diamminebichloroplatinum as a Therapeutic Agent in Metastatic Transitional Cell CarcinomaJournal of Urology, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958